![]() |
Colorized electron microscopy shows a chain of Streptococcus pyogenes bacteria between two immune cells. Image Credit: National Institute of Allergy and Infectious Diseases |
Researchers at Harvard Medical School have discovered that a molecule made by Streptococcus pyogenes — the bacterium that causes strep throat and other infections — could help explain several long-standing medical mysteries:
- Why strep sometimes leads to serious immune complications, including rheumatic fever.
- How the immune system's recognition of the molecule may contribute to diseases like lupus.
- Why one of the first cancer immunotherapies showed promise more than 100 years ago.
- How current immune therapies for cancer could be more effective.
The findings also contradict a long-standing belief that the immune system ignores this bacterial molecule and could propel efforts to tame or activate the immune system to treat a range of diseases.
The team, led by the lab of HMS biochemist Jon Clardy, published its findings in the Journal of the American Chemical Society.
“We were very surprised by the results, but the data were compelling,” said Clardy, the Christopher T. Walsh PhD Professor of Biological Chemistry and Molecular Pharmacology in the Blavatnik Institute at HMS.